TrialBMC neurology2016

ALAIN01--Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential.

Tobias Ruck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.